Ethics, economics, and the use of primaquine to reduce falciparum malaria transmission in asymptomatic populations

Yoel Lubell; Lisa White; Sheila Varadan; Tom Drake; Shunmay Yeung; Phaik Yeong Cheah; Richard J Maude; Arjen Dondorp; Nicholas P J Day; Nicholas J White; Michael Parker

doi:10.1371/journal.pmed.1001704

Ethics, economics, and the use of primaquine to reduce falciparum malaria transmission in asymptomatic populations

PLoS Med. 2014 Aug 19;11(8):e1001704. doi: 10.1371/journal.pmed.1001704. eCollection 2014 Aug.

Authors

Affiliations

¹ Mahidol-Oxford Tropical Medicine Research Unit, Faculty of Tropical Medicine, Mahidol University, Bangkok, Thailand; Centre for Tropical Medicine, Nuffield Department of Medicine, University of Oxford, United Kingdom.
² International Commission of Jurists, Geneva, Switzerland.
³ Faculty of Public Health and Policy, The London School of Hygiene & Tropical Medicine, London, United Kingdom.
⁴ The Ethox Centre, Nuffield Department of Population Health, University of Oxford, United Kingdom.

Abstract

Yoel Lubell and colleagues consider ethical and economic perspectives on mass drug administration of primaquine to limit transmission of P. falciparum malaria. Please see later in the article for the Editors' Summary.

Publication types

Research Support, Non-U.S. Gov't

MeSH terms

Antimalarials / adverse effects
Antimalarials / economics
Antimalarials / therapeutic use*
Drug Therapy / economics*
Drug Therapy / ethics*
Glucosephosphate Dehydrogenase Deficiency / diagnosis
Glucosephosphate Dehydrogenase Deficiency / epidemiology
Humans
Malaria, Falciparum / economics
Malaria, Falciparum / prevention & control*
Malaria, Falciparum / transmission
Plasmodium falciparum
Primaquine / adverse effects
Primaquine / economics
Primaquine / therapeutic use*

Substances

Antimalarials
Primaquine

Abstract

Publication types

MeSH terms

Substances

Grants and funding